Search Result "her-2"
HER-2 Signaling and Inhibition in Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 419-438
Author(s): B. C. Browne, N. OBrien, M. J. Duffy, J. Crown, N. ODonovan
Insight into the Medicinal Chemistry of EGFR and HER-2 Inhibitors
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 11 Year: 2014 Page: 1336-1350
Author(s): C. Wang,H. Gao,J. Dong,F. Wang,P. Li,J. Zhang
HER-2 / neu and Topoisomerase IIα - Simultaneous Drug Targets in Cancer
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 6 Issue: 5 Year: 2003 Page: 455-470
Author(s): Tero AH Jarvinen, Edison T Liu
Simultaneous Amplification of HER-2 (ERBB2) and Topoisomerase IIα (TOP2A) Genes - Molecular Basis for Combination Chemotherapy in Cancer
Journal: Current Cancer Drug Targets
Volume: 6 Issue: 7 Year: 2006 Page: 579-602
Author(s): Tero A.H. Jarvinen, Edison T. Liu
Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 2 Year: 2009 Page: 148-162
Author(s): Philippe L. Bedard, Evandro de Azambuja, Fatima Cardoso
HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 5 Year: 2008 Page: 488-496
Author(s): Christian Widakowich, Phuong Dinh, Evandro de Azambuja, Ahmad Awada, Martine Piccart-Gebhart
The FJQR Has Synergistic Effect with Fluoropyrimidine in the MaintenanceTreatment for HER-2 Negative Gastric Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 19 Issue: 2 Year: 2024 Page: 165-175
Author(s):
Antibody-Based Imaging of HER-2: Moving into the Clinic
Journal: Current Molecular Medicine
Volume: 13 Issue: 1 Year: 2013 Page: 1523-1537
Author(s): R. E. Wang, Y. Zhang, L. Tian, W. Cai, J. Cai
Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?
Journal: Reviews on Recent Clinical Trials
Volume: 10 Issue: 2 Year: 2015 Page: 82-89
Author(s): Matias E. Valsecchi,Enrique Diaz-Canton
Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2999-3019
Author(s): V. Tolmachev